隐形觅翠
Lv3
360 积分
2024-03-14 加入
-
NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
22小时前
已完结
-
CD11b agonists offer a novel approach for treating lupus nephritis
3天前
已完结
-
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy
16天前
已完结
-
The Angiotensin AT2Receptor: From a Binding Site to a Novel Therapeutic Target
16天前
已完结
-
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
-
POS1200 MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL
1个月前
已关闭
-
A comprehensive review of GPR84: A novel player in pathophysiology and treatment
1个月前
已完结
-
Ulcerative colitis
1个月前
已完结
-
Appendicectomy: a novel treatment for ulcerative colitis?
1个月前
已关闭
-
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
2个月前
已完结